Phibro Animal Health Key Fundamental And Technical Indicators

Stocks . USA . 
Stock . Phibro Animal Health
PAHC Stock  USD 56.24  1.56  2.85%   
Standard valuation, profitability, and solvency ratios for Phibro Animal are consolidated. At a P/E of 11.39 and a 6.29% profit margin, Phibro Animal sits in this range among its peers. Shareholder equity produces a 31.8% return, and current assets cover current liabilities 2.97 times. As of 5th of May 2026, RSI for Phibro Animal stands at 52, indicating neutral momentum. A reading near 50 often appears during transitional phases when a prior trend is consolidating before resuming or reversing.
Momentum
 Impartial
52
OversoldOverbought
As of the 5th of May, Phibro Animal reflects a market price of 56.24 per share. Current technical metrics show Semi Deviation of 2.28, risk adjusted performance of 0.152, and Coefficient Of Variation of 672.13. Technical analytics evaluate momentum, liquidity, and volatility relationships. Current statistics are evaluated within a broader sector context.
Cycles Operators Shifting Impulse Patterns Depth Overlaps Statistics Volatility Volume
Financial statement analysis for Phibro Animal combines income trends, asset quality, and liquidity assessment. Key drivers essential for forming an accurate valuation are shown below: Phibro Animal's financial statements quantify how the business generates, deploys, and retains capital.
Phibro Animal Health does not currently have any fundamental trend indicators for analysis. Equity Screeners allow side-by-side comparison of key metrics across the investment universe. Wider market screening provides additional reference points for Phibro Animal.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Profitability
Analysis
Details
Earnings
Projections
Details

Phibro Animal's Return on Equity (ROE) measures how effectively a company converts shareholders' equity into net income. It is calculated by dividing net income by average shareholders' equity, and it reflects management's ability to generate profit from the capital investors have committed. ROE is one of the most widely used profitability ratios because it ties directly to shareholder value creation.

Return On Equity

 = 

Net Income

Total Equity

Current Phibro Animal Return On Equity TTM
    
  0.32  
For investors studying Phibro Animal, Return On Equity TTM gives a clear data point within a larger valuation view. The link between Phibro Animal's core metrics and market price helps shape the investment case.
Competition

Phibro Animal Health Fundamental Drivers Relationships

Main Technical Indicators as of May 5, 2026

Cycle Indicators
Math Operators
Math Transform
Momentum Indicators
Overlap Studies
Pattern Recognition
Price Transform
Statistic Functions
Volatility Indicators
Volume Indicators
Risk Adjusted Performance0.152
Market Risk Adjusted Performance0.4144
Mean Deviation2.55
Semi Deviation2.28
Downside Deviation2.52
Coefficient Of Variation672.13
Standard Deviation3.87
Variance14.96
Information Ratio0.1493
Jensen Alpha0.5821
Total Risk Alpha0.6128
Sortino Ratio0.2292
Treynor Ratio0.4044
Maximum Drawdown28.74
Value At Risk-4.15
Potential Upside5.92
Downside Variance6.34
Semi Variance5.19
Expected Short fall-3.22
Skewness2.69
Kurtosis14.21

Daily Market Strength Indicators

Rate of Change and Momentum readings for Phibro Animal measure the velocity of recent price moves rather than direction alone. These indicators add context to how recent sessions in Phibro Animal have behaved. These indicators are most informative when viewed alongside Phibro Animal's volume profile and volatility measures.
Accumulation Distribution6810.25
Daily Balance Of Power0.7429
Rate Of Daily Change1.03
Day Median Price56.12
Day Typical Price56.16
Price Action Indicator0.9
Period Momentum Indicator1.56
Relative Strength Index52.82

Basic Forecasting Models

Fibonacci retracement levels applied to Phibro Animal Stock price swings identify potential support and resistance zones. Extreme price moves in Phibro Animal occur more frequently than standard risk models assume. Support and resistance levels derived from Phibro Animal's historical data identify zones where buying or selling pressure has stalled moves.
Naive Prediction
Simple Exponential Smoothing
Double Exponential Smoothing
Triple Exponential Smoothing
Simple Regression
Polynomial Regression
Simple Moving Average
4 Period Moving Average
8 Period Moving Average
20 Period Moving Average

Phibro Animal Related Equities

Phibro Animal's market space within the Health Care space is illustrated by the firms listed below. Revenue and margin checks across this group help investors set expectations for Phibro Animal's results. Sector-wide trends across this peer group split company-level factors from broader forces.
 Risk & Return  Correlation

Return On Equity TTM Peer Comparison

Stock peer comparison using Return On Equity TTM is a widely accepted framework for evaluating Phibro Animal within its group. Investors who find Phibro Animal's Return On Equity TTM more favorable than peers may view Phibro Animal as attractively valued. Peer dispersion in Return On Equity TTM across the group provides context for evaluating Phibro Animal's competitive positioning.
Phibro Animal is currently under evaluation for return on equity ttm relative to top peers.

Important Fundamentals

Return On Equity TTM0.32
Return On Asset TTM0.0834
Profit Margin TTM0.0629
Operating Margin TTM0.15
Current Valuation2.92 B
Shares Outstanding20.62 M
Shares Owned By Insiders1.01 %
Shares Owned By Institutions97.47 %
Number Of Shares Shorted1.25 M
Price To Earnings TTM11.39 X
Price To Book TTM6.69 X
Price To Sales TTM1.51 X
Revenue TTM1.3 B
Gross Profit TTM473.02 M
EBITDA TTM146.85 M
Net Income TTM48.26 M
Cash And Equivalents TTM98.67 M
Cash Per Share TTM2.44 X
Total Debt TTM761.55 M
Debt To Equity TTM1.79 %
Current Ratio TTM2.97 X
Book Value Per Share TTM8.20 X
Cash Flow From Operations TTM80.12 M
Short Ratio TTM3.84 X
Earnings Per Share2.26 X
Price To Earnings To Growth1.68 X
Target Price51.2
Number Of Employees2.48 K
Trailing Beta0.61
Market Capitalization TTM2.22 B
Total Asset TTM1.36 B
Retained Earnings TTM272.7 M
Working Capital TTM517.13 M
Current Asset TTM342.83 M
Current Liabilities TTM108.78 M
Annual Yield0.01 %
Five Year Return1.85 %
Net Asset1.36 B
Last Dividend Paid0.48

Financial Metrics, Fundamentals & Methodology

Phibro Animal's operating framework helps explain margin behavior, earnings persistence, and funding capacity. Debt exposure shapes how much financial pressure Phibro Animal could face in weaker periods. In recent filings, Phibro Animal reported revenue of 1.3 billion, positive EPS of 2.26, operating margin of 14.71% as of the latest reporting period.

Phibro Animal Health metrics are compiled from periodic company reporting and market reference feeds and normalized before display. Accounting-line values follow GAAP or IFRS structures as published in issuer filings.

Editorial review and methodology oversight provided by: Raphi Shpitalnik, Junior Member of Macroaxis Editorial Board


 
Tools
Analysis
Directory
Company
2026 Macroaxis LLC Made with in San Francisco
Privacy Terms Widgets Feedback
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and conditions page.